NextAR Spine Platform— 510(k) K233172
Substantially EquivalentMedacta International S.A.
FDA 510(k) clearance K233172 for NextAR Spine Platform, Substantially Equivalent on 2024-04-24. Applicant: Medacta International S.A..
Clearance details
- Applicant
- Medacta International S.A.
- Product code
- Code SBF
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Castel San Pietro (Ch), CH
Data sourced from openFDA. This site is unofficial and independent of the FDA.